While the diabetes-related risk for coronary heart disease has declined among White patients since 1990, it has doubled among Black patients.9 Therefore, a better understanding of the barriers to GLP-1 RA use among this population and other marginalized groups is needed. The gene discussed is GLP1R; the disease is coronary artery disorder.